NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

dennisdave,

Flaskworks is owned by NWBO. When Advent begins to use Flaskworks commercially the amount they get paid for manufacturing from NWBO should be reduced substantially not only because of reduced man hours to produce and release but also because of any use of this tech for any purpose other than for L. So you see, while Advent is not currently generating a direct financial net positive benefit to NWBO, there will be a substantial benefit once interim reimbursement measures are put into place, Flaskworks is approved and those desiring to pay for any of the products produced for the sake of business or research grant survival start showing up.
The big fish are not the only ones with a great deal at stake with the introduction of a new commercial scale tech under development and those who get in sooner rather than later with NWBO probably have the best chance to hang on. You can rest assured that ALL contracts for production of L after an approval decision will have eyes on by those who WILL hold Linda, Toucan and Advent accountable. Once commercial manufacturing starts, development stage will have passed by with trade secrets kept in house. That is the time for Advent and Toucan interests to take the back seat to NWBO’s broader investor base which then might have eyes fixed on how the 25% of outstanding shares set aside for hiring and retaining employees is being utilized for such purposes post approval when most seem to have ended up with current management in the past; ). At least this seems to be what Investor082 is pointing towards. Best wishes.